Abstract
Biomarkers of periodontal disease activity may be obtained from potential proteolytic and hydrolytic enzymes of inflammatory cell origin. Commercial diagnostic tests and those under development are discussed along with their advantages and disadvantages
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Rights and permissions
About this article
Cite this article
Eley, B., Cox, S. Advances in periodontal diagnosis. 8. Commercial diagnostic kits based on GCF proteolytic and hydrolytic enzyme levels. Br Dent J 184, 373–376 (1998). https://doi.org/10.1038/sj.bdj.4809636
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bdj.4809636
